Market
First country to approve AI-driven mRNA cancer vaccines by end of 2025?
2
Resolution / Starting Odds
USA • 25%
EU • 25%
China • 25%
Other • 25%
Official announcements from government health departments or reputable news outlets
Story
Oracle CEO Larry Ellison Announces AI-Driven mRNA Cancer Vaccines in 48 Hours
Jan 21, 2025, 11:29 PM
Oracle Corp. CEO Larry Ellison announced that artificial intelligence (AI) will soon enable the design and robotic production of personalized mRNA vaccines against cancer within 48 hours. Speaking at the White House, Ellison highlighted the potential of AI in early cancer detection through blood tests and subsequent gene sequencing of cancer tumors to develop custom vaccines. This initiative is part of Oracle's broader efforts, including the Stargate Project, which aims to build the world's largest computer to advance AI applications in healthcare, including cancer vaccines, personalized medicine, and pandemic prevention. Ellison mentioned that Oracle is using tools provided by Sam and Masa for this project.
View original story
Similar markets
United States • 25%
Other • 25%
Germany • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
United Kingdom • 25%
United States • 25%
United States • 25%
Other • 25%
Germany • 25%
United Kingdom • 25%
India • 25%
China • 25%
Brazil • 25%
Other • 25%
Moderna • 25%
Oracle • 25%
Other • 25%
Pfizer • 25%
Other • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Canada • 25%
United States • 25%
Australia • 25%
United Kingdom • 25%
No countries • 25%
1 to 5 countries • 25%
6 to 10 countries • 25%
More than 10 countries • 25%
California • 25%
Other • 25%
New York • 25%
Texas • 25%
European Union • 25%
United States • 25%
United Kingdom • 25%
Other • 25%